Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome

Overview of attention for article published in Molecular Cancer, September 2008

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 89 Dimensions

Readers on

mendeley: 75 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

EPLIN AS A BIOMARKER FOR CANCER

Application WO-2021205078-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.